Yinduolan Pharmaceutical

Xinjiang Yinduolan Pharmaceutical is a leading Chinese pharmaceutical company specializing in the modernization and production of Traditional Uyghur Medicine (TUM). Based in Urumqi, Xinjiang, the company integrates R&D, manufacturing, and sales, focusing primarily on respiratory, anti-viral, and anti-inflammatory treatments. Its flagship product, Fufang Yizhihao Granules, is widely recognized in China for treating influenza and upper respiratory tract infections. Yinduolan operates a state-of-the-art manufacturing base and is a key player in the industrialization of ethnic minority medicines in China. The company is a subsidiary of the Hualing Group and is listed on the New Third Board in China.